Results
1 -
10 of
11Oral Thrombin Inhibitors: Challenges and Progress, Antithrombotics Pharmacokinetics of an emerging new class of anticoagulant/antithrombotic drugs, European Journal of Clinical Pharmacology Thrombin inhibitors with novel P1 binding pocket functionality: free energy of binding analysis, Journal of Molecular Modeling Impact of Extracellular Protein Binding on Passive and Active Drug Transport Across Caco-2 Cells, Pharmaceutical Research Effects of Intravenous Enoxaparin and Intravenous Inogatran in an Electrolytic Injury Model of Venous Thrombosis in the Dog, Journal of Thrombosis and Thrombolysis Antithrombotic Effect of LB-30057 (CI-1028), a New Synthetic Thrombin Inhibitor, in a Rabbit Model of Thrombosis: Comparison with Inogatran, Journal of Thrombosis and Thrombolysis Inhibition of Binding of an Enzymatically Stable Thrombin Inhibitor to Lumenal Proteases as an Additional Mechanism of Intestinal Absorption Enhancement, Pharmaceutical Research Inogatran vs heparin in unstable CAD: a tie?, Inpharma Weekly